VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/36710403/

⇱ Aspergillus infection in chronic obstructive pulmonary diseases - PubMed

Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic airway non-specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients.

Keywords: chronic obstructive pulmonary disease (COPD); chronic pulmonary aspergillosis (CPA); invasive pulmonary aspergillosis (IPA).

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

👁 FIGURE 1
FIGURE 1
Modified diagnostic procedure and treatment for IPA in COPD patients
👁 FIGURE 2
FIGURE 2
Diagnostic procedures and treatment for CPA in COPD patients
👁 FIGURE 3
FIGURE 3
Diagnostic procedures and treatment for aspergillus sensitisation in COPD patients

References

    1. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121(6):1988‐1999. doi: 10.1378/chest.121.6.1988 - DOI - PubMed
    1. Tudesq JJ, Peyrony O, Lemiale V, Azoulay E. Invasive pulmonary aspergillosis in nonimmunocompromised hosts. Semin Respir Crit Care Med. 2019;40(4):540‐547. doi: 10.1055/s-0039-1696968 - DOI - PubMed
    1. Fréalle E, Reboux G, Le Rouzic O, et al. Impact of domestic mould exposure on aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary disease. Environ Res. 2021;195:110850. doi: 10.1016/j.envres.2021.110850 - DOI - PubMed
    1. Alastruey‐Izquierdo A, Cadranel J, Flick H, et al. Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Respiration. 2018;96(2):159‐170. doi: 10.1159/000489474 - DOI - PubMed
    1. Bulpa P, Duplaquet F, Dimopoulos G, Vogelaers D, Blot S. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease exacerbations. Semin Respir Crit Care Med. 2020;41(6):851‐861. doi: 10.1055/s-0040-1702210 - DOI - PubMed

Publication types

MeSH terms

Supplementary concepts

Grants and funding

LinkOut - more resources

Full text links
👁 Wiley full text link
Wiley Free PMC article
Cite
Send To

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.